Latest Report On Biologics And Biosimilars Market Forecast To 2021


Posted December 7, 2016 by sayali

This report focuses on the Biologics and Biosimilars in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa.

 
"A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
"
[b]Scope of the Report:[/b]
This report focuses on the Biologics and Biosimilars in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

[b]To Request Sample Copy of This Report: http://www.marketresearchglobe.com/request-sample/91600[/b]

Market Segment by Manufacturers, this report covers
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type, covers
Antibody
Hormone
Growth Factors
Other

Market Segment by Applications, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

[b]Browse Complete Report http://www.marketresearchglobe.com/report/global-biologics-and-biosimilars-market-by-manufacturers-regions-type-and-application-forecast-to-2021[/b]

There are 13 Chapters to deeply display the global Biologics and Biosimilars market.

Chapter 1, to describe Biologics and Biosimilars Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Biologics and Biosimilars, with sales, revenue, and price of Biologics and Biosimilars, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Biologics and Biosimilars, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Biologics and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Biologics and Biosimilars sales channel, distributors, traders, dealers, appendix and data source.

About Us:
Market Research Globe is a proficient consulting company offering services associated to global market research. With assistance from ingenious database made by experts, it provides its customers a vast variety of customized marketing and business research solutions to choose from.
Contact us:
+1-888-376-9998
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By market research globe
Country India
Categories Business
Tags biologics , biosimilars , market
Last Updated December 7, 2016